Chronic pain has been identified as an important issue related to various rheumatic diseases. At the time of a major government spending review, it is appropriate to discuss the pain characterising rheumatic diseases and its related costs. It is clearly essential for healthcare authorities to rationalise their policies on the basis of the increasing expectations of the users of healthcare services while simultaneously balancing their books. There are few published studies concerning the costs of pain of any kind, and the same is true of the costs of the chronic pain associated with diseases such as rheumatoid arthritis, osteoarthritis, and fibromyalgia.
Costs of pain in rheumatology / A. Marsico, F. Atzeni, A. Piroddi, M. Cazzola, S. Stisi, P. Sarzi-Puttini. - In: REUMATISMO. - ISSN 0048-7449. - 66:1(2014 Jun), pp. 103-107.
|Titolo:||Costs of pain in rheumatology|
|Parole Chiave:||Chronic pain; Direct costs; Indirect costs; Intangible costs; Acute Pain; Analgesics; Antirheumatic Agents; Arthritis, Rheumatoid; Chronic Pain; Drug Costs; Europe; Fibromyalgia; Health Expenditures; Health Policy; Health Resources; Health Services Needs and Demand; Humans; Italy; Musculoskeletal Pain; Osteoarthritis; Prescription Fees; Quality of Life; Rheumatic Diseases; United States; Cost of Illness; Rheumatology; Medicine (all)|
|Settore Scientifico Disciplinare:||Settore MED/16 - Reumatologia|
|Data di pubblicazione:||giu-2014|
|Digital Object Identifier (DOI):||http://dx.doi.org/10.4081/reumatismo.2014.771|
|Appare nelle tipologie:||01 - Articolo su periodico|